Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone monotherapy in bipolar depression (Study 404)
NCT03249376Phase 3Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of lumateperone in bipolar disorder (BD), sponsored by Intra-Cellular Therapies. Started Nov 2017; status: completed.
02
Drugs
lumateperone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03249376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249376.